Literature DB >> 23131606

Repeated exposure to modern volatile anaesthetics may cause chronic hepatitis as well as acute liver injury.

Amanda Nicoll1, David Moore, Dolores Njoku, Brad Hockey.   

Abstract

Volatile anaesthetic agents are known to cause acute hepatitis and fulminant hepatic failure in susceptible individuals. Four patients were identified with prolonged liver injury due to volatile anaesthetic-induced hepatitis. Three had liver biopsy confirmation and all gave blood for specific diagnostic tests (TFA and CYP 2E1 IgG4 antibodies). The Roussel Uclaf Causality Assessment Method (RUCAM) drug causality scale was used to determine the likelihood of volatile anaesthetics causing the chronic liver injury. We describe four cases of volatile anaesthetic hepatitis in which three evolved into chronic hepatitis. The fourth followed a more typical pattern of acute hepatitis; however, resolution took a few months. These cases all occurred with modern volatile anaesthetics, predominantly sevoflurane, and all cases were proven with specific antibody tests, liver histology and a drug causality scale. This is the first report of chronic liver injury due to volatile anaesthetic exposure.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23131606      PMCID: PMC3666850          DOI: 10.1136/bcr-2012-006543

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  34 in total

1.  [Volatile anesthetics and liver injury: a clinical update or what every anesthesiologist should know].

Authors:  Jackie L Martin
Journal:  Can J Anaesth       Date:  2005-02       Impact factor: 5.063

Review 2.  Idiosyncratic drug reactions: past, present, and future.

Authors:  Jack Uetrecht
Journal:  Chem Res Toxicol       Date:  2007-12-04       Impact factor: 3.739

Review 3.  Inhaled anesthetic agents.

Authors:  Joan Stachnik
Journal:  Am J Health Syst Pharm       Date:  2006-04-01       Impact factor: 2.637

4.  Propofol-induced acute toxic hepatitis after brief sedation for endoscopic retrograde cholangiopancreatography.

Authors:  F J Polo-Romero; P Paricio; A Tovar; J M Alonso
Journal:  Endoscopy       Date:  2008-02-26       Impact factor: 10.093

Review 5.  Mitochondrial abnormalities--a link to idiosyncratic drug hepatotoxicity?

Authors:  Urs A Boelsterli; Priscilla L K Lim
Journal:  Toxicol Appl Pharmacol       Date:  2006-12-22       Impact factor: 4.219

6.  Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry.

Authors:  Raúl J Andrade; M Isabel Lucena; Neil Kaplowitz; Beatriz García-Muņoz; Yolanda Borraz; Ketevan Pachkoria; Miren García-Cortés; M Carmen Fernández; Gloria Pelaez; Luis Rodrigo; José A Durán; Joan Costa; Ramón Planas; Anabel Barriocanal; Carlos Guarner; Manuel Romero-Gomez; Teresa Muņoz-Yagüe; Javier Salmerón; Ramón Hidalgo
Journal:  Hepatology       Date:  2006-12       Impact factor: 17.425

7.  Post-halothane jaundice in relation to previous administration of halothane.

Authors:  W W Mushin; M Rosen; E V Jones
Journal:  Br Med J       Date:  1971-07-03

8.  Long-term follow-up of patients with mild to moderate drug-induced liver injury.

Authors:  E Björnsson; E Kalaitzakis; V Av Klinteberg; N Alem; R Olsson
Journal:  Aliment Pharmacol Ther       Date:  2007-07-01       Impact factor: 8.171

9.  Desflurane hepatitis associated with hapten and autoantigen-specific IgG4 antibodies.

Authors:  James S Anderson; Noel R Rose; Jackie L Martin; Edmond I Eger; Dolores B Njoku
Journal:  Anesth Analg       Date:  2007-06       Impact factor: 5.108

10.  Role of CYP2E1 immunoglobulin G4 subclass antibodies and complement in pathogenesis of idiosyncratic drug-induced hepatitis.

Authors:  Dolores B Njoku; Jenelle L Mellerson; Monica V Talor; Douglas R Kerr; Nauder R Faraday; Ingrid Outschoorn; Noel R Rose
Journal:  Clin Vaccine Immunol       Date:  2006-02
View more
  4 in total

1.  Combined Laparoscopic Splenectomy and Esophagogastric Devascularization versus Open Splenectomy and Esophagogastric Devascularization for Portal Hypertension due to Liver Cirrhosis.

Authors:  Hong-Ping Luo; Zhan-Guo Zhang; Xin Long; Fei-Long Liu; Xiao-Ping Chen; Lei Zhang; Wan-Guang Zhang
Journal:  Curr Med Sci       Date:  2020-03-13

Review 2.  The Slo(w) path to identifying the mitochondrial channels responsible for ischemic protection.

Authors:  Charles Owen Smith; Keith Nehrke; Paul S Brookes
Journal:  Biochem J       Date:  2017-06-09       Impact factor: 3.857

3.  A retrospective case-controlled cohort study of inpatient drug induced liver injury: the RIDDLE study.

Authors:  Thomas Worland; Ken Lee Chin; Beverley Rodrigues; Amanda Nicoll
Journal:  Transl Gastroenterol Hepatol       Date:  2020-07-05

4.  Toxic responses of the liver and kidneys following occupational exposure to anesthetic gases.

Authors:  Masoud Neghab; Fatemeh Amiri; Esmaeel Soleimani; Saeed Yousefinejad; Jafar Hassanzadeh
Journal:  EXCLI J       Date:  2020-03-25       Impact factor: 4.068

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.